Prenetics Global Limited (PRENW)
USD 0.01
(3.23%)
USD 0.01
(3.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 44.01 Million USD | -35.22% |
| 2022 | 67.93 Million USD | -87.63% |
| 2021 | 549.4 Million USD | 1047.55% |
| 2020 | 47.87 Million USD | 273.05% |
| 2019 | 12.83 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 42.3 Million USD | 3.63% |
| 2024 Q1 | 40.82 Million USD | -7.25% |
| 2023 Q3 | 47.63 Million USD | -21.43% |
| 2023 FY | 44.01 Million USD | -35.22% |
| 2023 Q4 | 44.01 Million USD | -7.59% |
| 2023 Q2 | 60.62 Million USD | 5.41% |
| 2023 Q1 | 57.51 Million USD | -15.35% |
| 2022 Q2 | 59.24 Million USD | -90.04% |
| 2022 Q1 | 594.61 Million USD | 8.23% |
| 2022 Q4 | 67.93 Million USD | 8.99% |
| 2022 FY | 67.93 Million USD | -87.63% |
| 2022 Q3 | 62.33 Million USD | 5.22% |
| 2021 FY | 549.4 Million USD | 1047.55% |
| 2021 Q1 | 67.71 Million USD | 41.45% |
| 2021 Q3 | 34.47 Million USD | 10.1% |
| 2021 Q4 | 549.4 Million USD | 1493.68% |
| 2021 Q2 | 31.31 Million USD | -53.76% |
| 2020 Q4 | 47.87 Million USD | 0.0% |
| 2020 FY | 47.87 Million USD | 273.05% |
| 2019 FY | 12.83 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 40.22 Million USD | -9.415% |
| Biodesix, Inc. | 94.51 Million USD | 53.433% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -1207.468% |
| Castle Biosciences, Inc. | 86.54 Million USD | 49.142% |
| DarioHealth Corp. | 38.24 Million USD | -15.082% |
| Exact Sciences Corporation | 3.32 Billion USD | 98.677% |
| IDEXX Laboratories, Inc. | 1.77 Billion USD | 97.521% |
| Illumina, Inc. | 4.36 Billion USD | 98.992% |
| Intelligent Bio Solutions Inc. | 5.59 Million USD | -686.559% |
| iSpecimen Inc. | 6.07 Million USD | -624.133% |
| Standard BioTools Inc. | 159.86 Million USD | 72.468% |
| 23andMe Holding Co. | 206.64 Million USD | 78.701% |
| Medpace Holdings, Inc. | 1.09 Billion USD | 95.991% |
| NeoGenomics, Inc. | 739.69 Million USD | 94.05% |
| Inotiv, Inc. | 588.04 Million USD | 92.515% |
| Psychemedics Corporation | 6.59 Million USD | -567.07% |
| Precipio, Inc. | 3.67 Million USD | -1098.618% |
| RadNet, Inc. | 2.07 Billion USD | 97.877% |
| Sotera Health Company | 2.68 Billion USD | 98.362% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -103.06% |
| Exagen Inc. | 34.25 Million USD | -28.506% |
| Natera, Inc. | 691.79 Million USD | 93.638% |
| Aspira Women's Health Inc. | 8.62 Million USD | -410.18% |
| Neogen Corporation | 1.44 Billion USD | 96.944% |
| Myriad Genetics, Inc. | 312.9 Million USD | 85.934% |
| ICON Public Limited Company | 7.74 Billion USD | 99.432% |
| Bionano Genomics, Inc. | 118.24 Million USD | 62.779% |
| CareDx, Inc | 223.28 Million USD | 80.288% |
| Check-Cap Ltd. | 1.33 Million USD | -3209.267% |
| Twist Bioscience Corporation | 152.97 Million USD | 71.228% |
| Guardant Health, Inc. | 1.62 Billion USD | 97.296% |
| BioNexus Gene Lab Corp. | 1.74 Million USD | -2426.678% |
| Fulgent Genetics, Inc. | 139.82 Million USD | 68.522% |
| Sera Prognostics, Inc. | 25.28 Million USD | -74.082% |
| OPKO Health, Inc. | 622.47 Million USD | 92.929% |
| Personalis, Inc. | 95.65 Million USD | 53.989% |
| Applied DNA Sciences, Inc. | 8.77 Million USD | -401.338% |
| Star Equity Holdings, Inc. | 21.67 Million USD | -103.06% |
| MDxHealth SA | 121.92 Million USD | 63.901% |
| Prenetics Global Limited | 44.01 Million USD | 0.0% |
| ENDRA Life Sciences Inc. | 1.09 Million USD | -3918.898% |
| Mainz Biomed B.V. | 12.15 Million USD | -261.957% |
| Trinity Biotech plc | 83.38 Million USD | 47.216% |
| Neuronetics, Inc. | 81.64 Million USD | 46.089% |
| bioAffinity Technologies, Inc. | 3.36 Million USD | -1207.468% |